The US Court of Appeals for the Federal Circuit affirmed a lower-court decision in favor of Illumina, which Scripps had sued over marketing of bead-based microarrays.
Researchers saw signs of an unreported Zika virus outbreak in Cuba in 2017, well after the documented decline in new cases in Brazil and other parts of the world.
ScienceInsider reports Floyd Romesberg has been forced out from the Scripps Research Institute.
In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.
An analysis of B cell adaptive immune receptor sequences in 10 individuals uncovered exceptionally diverse antibody repertoires with a subset of shared antibody clonotypes.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.
There are some deep divisions between the three main databases, some due to competitive pressures and others because of the nature of metabolomics.
In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.
Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.
In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.
A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.
Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.
Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.
In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.